Guang Tan
-
- Cancer, Hypoxia, and Metabolism 2
-
- Peptidase Inhibition and Analysis 3
- Cancer Immunotherapy and Biomarkers 2
-
- Ubiquitin and proteasome pathways 5
- Histone Deacetylase Inhibitors Research 2
-
- Immunotherapy and Immune Responses 4
-
- Cancer Research and Treatments 2
-
- Autophagy in Disease and Therapy 2
- Co-authors
- Zhen NingJiwei LiuChang LuAman WangHaifeng LuoJinxiao LiangQiu YanWei Gao
- Partner nations
- China
In The Last Decade
Guang Tan
16 papers receiving 246 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 48
- Oncology 82
- Molecular Biology 160
- Molecular Medicine 9
- Immunology 36
Countries citing papers authored by Guang Tan
This map shows the geographic impact of Guang Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guang Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guang Tan more than expected).
Fields of papers citing papers by Guang Tan
This network shows the impact of papers produced by Guang Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guang Tan. The network helps show where Guang Tan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guang Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 8 | |
| 3 | 2022 | 19 | |
| 4 | 2022 | 9 | |
| 5 | 2022 | 11 | |
| 6 | 2021 | 4 | |
| 7 | 2020 | 6 | |
| 8 | 2019 | 13 | |
| 9 | 2018 | 55 | |
| 10 | 2017 | 49 | |
| 11 | 2017 | 35 | |
| 12 | 2015 | 2 | |
| 13 | 2012 | 4 | |
| 14 | 2011 | 15 | |
| 15 | 2007 | 12 | |
| 16 | [Therapeutic effects of treatment of pancreatic carcinoma by interleukin-23 and apoptotic cell antigen-modified dendritic cell vaccine: experiment with mice]. | 2006 | 2 |
About Guang Tan
Guang Tan is a scholar working on Cancer Research, Biotechnology and Oncology, having authored 16 papers that have together received 246 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (5 papers), Immunotherapy and Immune Responses (4 papers), Peptidase Inhibition and Analysis (3 papers), Cancer Research and Treatments (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Autophagy in Disease and Therapy (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Cancer Research (48 citations), Oncology (82 citations) and Molecular Biology (160 citations). Guang Tan has collaborated with scholars based in China. Frequent co-authors include Zhen Ning, Jiwei Liu, Chang Lu, Aman Wang, Haifeng Luo, Jinxiao Liang, Qiu Yan, Wei Gao, Zhikun Lin and Guowang Xu. Their work appears in journals such as Aging, Oncology Reports, Science of Advanced Materials, Journal of Immunology Research and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.